ABVC

Conviction 0HealthcareScan · Mon, Aug 10, 2026

Inverted hammer

ABVC$0.9584-6.04%

ResistanceSupportVol 14

Vol MA14 74.33K

May 11May 28Jun 16Jul 6Jul 23Aug 10

ABVC BIOPHARMA, INC.PHARMACEUTICAL PREPARATIONSwww.abvcpharma.com ↗

Price0.9584

Change-6.04%

Gap-6.24%

Rel volume0.15×

Avg volume78.45K

Avg $ vol88.46K

SMA 201.12

SMA 501.32

SMA 2001.70

Price vs 50-27.43%

Price vs 200-43.68%

MA stackbearish

50/200 cross—

Supertrenddown · 1.26

RSI (14)35

MACD hist-0.01

MACD cross—

Stoch %K / %D1 / 13

ADX (14)32

+DI / −DI12 / 27

RSI divergence—

MACD divergence—

ATR %+11.62%

ADR %8.04%

52w high3.30

52w low0.9094

From 52w high-70.96%

Above 52w low+5.39%

New 52w highNo

SqueezeOff

Bollinger width38.80%

%B0.13

Donchian pos0.44%

Donchian high1.42

Donchian low0.9564

AVWAP (52w high)1.72

vs AVWAP high-44.17%

AVWAP (52w low)1.37

vs AVWAP low-30.03%

OBV trendFlat

Chaikin MF (20)-0.21

Today vs 20d0.15×

Avg vol (14d)74.33K

Avg vol (20d)78.45K

Avg $ vol (20d)88.46K

Market cap—

RS 3m (vs SPY)-12.97%

RS 6m (vs SPY)-50.36%

RS line new highNo

Trend template0/8

Technical rank5.3

1 week-7.85%

1 month-36.53%

3 months-9.58%

6 months-44.92%

1 year-63.42%

YTD-56.24%

P/E-3.37

P/B2.47

P/S52.30

P/FCF-8.86

EPS-0.3900

Div yield—

ROE-73.41%

ROA-40.08%

Debt/Eq0.02

Current0.12

EV/EBITDA-3.75

Gross margin99.85%

Net margin—

Rev growth0.00%

EPS growth-61.30%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value26.72M

Revenue795.95K

Net income-1.56M

Gross profit795.95K

Free cash flow-3.01M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out26M

Employees19

ListedTue, Nov 9, 2004

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank5.3 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmInverted hammer

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ABVC

All disclosures →

No recent disclosed trades by Congress in ABVC. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ABVC

No recent insider (Form 4) filings in ABVC. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in ABVC · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.